Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 281 (abbreviated as RNA5SP281) is a predicted human pseudogene related to 5S ribosomal RNA[2]. Pseudogenes are DNA sequences resembling functional genes but are typically non-functional due to the accumulation of disabling mutations or lack of regulatory elements required for expression[5]. The 5S ribosomal RNA gene is normally a component of the ribosome, crucial for ribosome structure and translation in the cell[1][3][5]. Pseudogenes like RNA5SP281 are not transcribed into functional 5S rRNA and do not participate in ribosome biogenesis or function[5]. While some pseudogenes can exert regulatory effects (such as acting as competitive endogenous RNAs), there is no evidence that RNA5SP281 encodes any functional RNA or has any direct biological or pathological role[2][5]. Some pseudogenes, including other 5S ribosomal pseudogenes, have been broadly implicated as potential genetic markers for cancer sub-classification due to altered expression patterns in tumors, but RNA5SP281 has no established functional or disease role, nor is it a therapeutic target[4][6]. Justification for "is_incorrect": RNA5SP281 is not a receptor, enzyme, transporter, or therapeutic target but rather a pseudogene—a non-functional segment related to 5S rRNA[2][5]. Thus, treating it as a therapeutic "target" is conceptually incorrect. It is not druggable, is not implicated in recognized disease pathways, and has no validated biological activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 281 (RNA5SP281).